20 (AIDX) Gross Margin (2025 - 2026)
20's (AIDX) quarterly Gross Margin came in at 17.8% in Q1 2026, down 1214.0% YoY from 1.6% in Q1 2025, and down 40.56% on a QoQ basis from 29.94% in Q1 2025.
20 (AIDX) Gross Margin (2025 - 2026) Analysis & Trends
20 (AIDX) has 2 years of Gross Margin data on file, last reported at 17.8% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 45.84% |
| 10 | 20 | 5.45 Mn | 905,333.06 | 304,727.00 | 41.71% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.80% |
| Mar 31, 2025 | 29.94% |